Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $168.8700 (1.13%) ($166.0400 - $174.8100) on Thu. Oct. 25, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.84% (three month average) | RSI | 12 | Latest Price | $168.8700(1.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -3.1% a day on average for past five trading days. | Weekly Trend | LGND declines -12.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.42% in a week (0% probabilities). VXX(-16%) TLT(-16%) VIXM(-12%) UUP(-9%) GDXJ(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.42% (StdDev 2.84%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
Resistance Level | $217.3 | 5 Day Moving Average | $178.2(-5.24%) | 10 Day Moving Average | $189.65(-10.96%) | 20 Day Moving Average | $217.3(-22.29%) | To recent high | -38.5% | To recent low | 1.1% | Market Cap | $2.714b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |